AbCellera starts trials of treatment for COVID-19 variants
AbCellera antibody intended for COVID-19 variants has entered clinical trials
Source: theglobeandmail.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Advisory Table. Real-time updates on events, politics, business and more.